Bioventix PLC | Balance Sheet

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,585.50
3,351.50
4,130.60
5,380.40
6,166.90
6,986.50
Total Accounts Receivable
356.60
373.80
412.90
451.20
3,342.70
3,816.80
Inventories
148.50
164.10
193.00
198.90
226.20
283.10
Other Current Assets
972.80
1,458.00
1,677.70
2,234.30
-
-
Total Current Assets
4,063.40
5,347.30
6,414.20
8,264.80
9,735.80
11,086.40
Net Property, Plant & Equipment
438.80
419.70
487.80
467.10
449.30
497.80
Total Investments and Advances
-
-
-
43.30
195.60
291.40
Intangible Assets
10.00
-
-
-
-
-
Total Assets
4,512.20
5,767.10
6,902.00
8,775.20
10,380.70
11,875.60
Accounts Payable
30.40
29.20
58.40
22.10
23.30
Income Tax Payable
158.60
429.60
176.00
408.80
-
Other Current Liabilities
110.80
72.10
63.10
119.00
196.70
Total Current Liabilities
299.70
530.90
297.50
549.90
219.90
Deferred Taxes
7.60
-
20.30
17.90
16.10
Total Liabilities
307.30
530.90
317.80
567.90
236.10
Common Equity (Total)
4,204.80
5,236.20
6,584.10
8,207.40
10,144.60
Total Shareholders' Equity
4,204.80
5,236.20
6,584.10
8,207.40
10,144.60
Total Equity
4,204.80
5,236.20
6,584.10
8,207.40
10,144.60
Liabilities & Shareholders' Equity
4,512.20
5,767.10
6,902.00
8,775.20
10,380.70

About Bioventix

View Profile
Address
7 Romans Business Park
Farnham Surrey GU9 7SX
United Kingdom
Employees -
Website http://bioventix.com
Updated 07/08/2019
Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom.